Editorial: The molecular landscape and promising therapeutic targets in aggressive B-cell non-Hodgkin lymphomas

Hanno Maximilian Witte; Axel Künstner; Emil Chteinberg; Francesco Piazza; Gaël Roué; Niklas Gebauer

doi:10.3389/fonc.2023.1278169

Editorial: The molecular landscape and promising therapeutic targets in aggressive B-cell non-Hodgkin lymphomas

Front Oncol. 2023 Aug 30:13:1278169. doi: 10.3389/fonc.2023.1278169. eCollection 2023.

Authors

Hanno Maximilian Witte^{1

2

3}, Axel Künstner^{3

4}, Emil Chteinberg⁵, Francesco Piazza⁶, Gaël Roué⁷, Niklas Gebauer^{2

3}

Affiliations

¹ Department of Hematology and Oncology, Bundeswehrkrankenhaus Ulm, Ulm, Germany.
² Department of Hematology and Oncology, University Hospital of Schleswig-Holstein, Lübeck, Germany.
³ University Cancer Center Schleswig-Holstein, University Hospital of Schleswig-Holstein, Lübeck, Germany.
⁴ Medical Systems Biology Group, University of Lübeck, Lübeck, Germany.
⁵ Institute of Human Genetics Ulm University and Ulm University Medical Center, Ulm, Germany.
⁶ Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova and Myeloma and Lymphoma Pathobiology Laboratory, Veneto Istituto of Molecular Medicine, Padova, Italy.
⁷ Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain.

No abstract available

Keywords: aggressive B-cell lymphoma; genomics; multi-omics; non-Hodgkin lymphoma; precision oncology; transcriptomics.

Publication types

Editorial

Grants and funding

HW received support from Soldatentumorhilfe and Stefan-Morsch-Stiftung. NG was supported by Stefan-Morsch-Stiftung, the Damp-Stiftung, the Wilhelm-Sander-Stiftung, the Jose Carreras Leukämie-Stiftung. GR was supported by the Spanish Ministry of Science and Innovation (PID2021-123039OB-C21) and the Catalan Agency for Management of University and Research Grants (2021SGR01535).